A Non-Interventional Registry Study of Systemic Antifungal Therapy in Adult Subjects with Invasive Mucormycosis or Invasive Aspergillosis Caused by a Non-fumigatus Species. Phase 4 Study of ASP9766 ISN/Protocol 9766-CL-0111, version 2.0

Grants and Contracts Details

StatusFinished
Effective start/end date12/7/16 → 6/11/20

Funding

  • inVentiv Health Clinical: $41,179.00